Granzymes A and B in pulmonary sarcoidosis (experimental study);Doseamento das granzimas A e B na sarcoidose pulmonar (estudo experimental)

Revista Portuguesa de Pneumologia

Volumn 11, Issue 2, 2005, Pages 111-133

  Dourado, Marília ^a   Bento, Joana ^a   Mesquita, Luís ^b   Marques, Alcide ^c   Vale Pereira, Sofia ^d   Sarmento Ribeiro, Ana Bela ^a   Mota Pinto, Anabela ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b Técnico Superior de 1a Classe   (Portugal)

^c Interna do Internato Complementar de Pneumologia   (Portugal)

^d Técnica Superior de 2a Classe   (Portugal)

Author keywords

Granzyme A; Granzyme B; Laboratorial diagnosis; Sarcoidosis

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; GRANZYME A; GRANZYME B;

ADULT; ANALYTICAL EQUIPMENT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTATION; FEMALE; HUMAN; INFLAMMATION; LUNG DISEASE; LUNG GRANULOMA; LUNG SARCOIDOSIS; MALE; STATISTICAL SIGNIFICANCE;

EID: 20144379827     PISSN: 08732159     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0873-2159(15)30495-5     Document Type: Article

References (57)

1. Anders Eklund, Aetiology, pathogenesis and treatment of sarcoidosis. J Inter Med 2003;253:2-3.
2. RM Du Bois, Goh N, McGrath D, Cullinan P. Is there a role for microorganisms in the pathogenesis of sarcoidosis? J Int Med 2003;253:4-17.
3. Neville Woolf. Some specific granulomatous disorders. In: Pathology - Basic and Systemic. London: WB Saunders Company Ltd; 1998. Ch:15; p. 157-172.
4. Alan Stevens, James Lowe. Tissue responses to damage. In: Pathology. 2nd ed. Edinburgh: Mosby; 2000. Ch: 4; p. 35-60.
5. Manfred Schürmann, Reichel P, Müller-Myhsok B, Dieringer T, Wurm K, Schlaak M et al. Angiotensin-converting enzyme (ACE) gene polymorphisms and familial occurrence of sarcoidosis. J Int Med 2001; 249:77-83.
6. Manfred W Ziegenhagen, Müller-Quernheim J. The cytokine network in sarcoidosis and its clinical relevance. J Int Med 2003;253:18-30.
7. Benjamin A Rybicki, Major M, Popovich JJr, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997;145(3):234-241.
8. DS McGrath, Daniil Z, Foley, du Bois JL, Lympany PA, Cullinan P, du Bois RM. Epidemiology of familial sarcoidosis in the UK. Thorax 2000;55:751-754.
9. Benjamin A Rybicki, Iannuzzi MC, Frederick MM, Thompson BW, Rossman MD, Bresnitz EA, et al. Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Resp Crit Care Med 2001;164:2085-2091.
10. J Müller-Quernheim. Sarcoidosis: immunopathogenetic concepts and their clinical application. Eur Resp J 1998;12(3):716-738.
11. M Luisetti, Beretta A, Casali L. Genetic aspects in sarcoidosis. Eur Resp J 2000;16(4): 768-780.
12. David R Moller. Treatment of sarcoidosis - from a basic science point of view. J Int Med 2003;253:31-40.
13. Yeager HJr, Williams MC, Beekman JF, Bayly TC, Beaman BL. Sarcoidosis: analysis of cells obtained by bronchial lavage. Am Rev Resp Dis 1977;116: 951-954.
14. Gary W Hunninghake, Crystal RG. Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med 1981;305(8):429-434.
15. Agostini C, Semenzato G. Cytokines in sarcoidosis. Semin Resp Infect 1998;13:184-190.
16. David R Moller, Forman JD, Liu MC, Noble PW, Greenlee BM, Vyas P, et al. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis.J Immunol 1996;156:4952-4960.
17. Stephen W Chensue, Warmington K, Ruth J, Lincoln P, Kuo M-C, Kunkel SL. Cytokine responses during mycobacterial and schistosomal antigen-induced pulmonary granuloma formation. 'Production of Th1 and Th2 cytokines and relative contribution of tumor necrosis factor. Am J Pathol 1994;145:1105-1113.
18. Ian M Orme, Cooper AM. Cytokine/chemokine cascade in immunity to tuberculosis. Immunol Today 1999 Jul;20(7):307-312.
19. Vestbo J, Viskum K. Respiratory symptoms at presentation and long-term vital prognosis in patients with pulmonary sarcoidosis. Sarcoidosis 1994;11:123-125.
20. Miura K, Takahashi K, Fukushi Y. Role of biochemical markers in Sarcoidosis (Abstract). Nippon Rinsho 2002;60(9):1741-1746.
21. Grosso M, Margollicci MA, Bargagli E, Buccoliero QR, Perrone A, Galimberti D, Morgese G, Balestri P, Rottoli P. Serum levels of chitotriosidase as a marker of disease activity clinical stage in sarcoidosis. Scand J Lab Invest 2004;64(1):57-62.
22. Guy M Tremblay, Wolbink AM, Cormier Y, Hack CE. Granzyme activity in the inflammed lung is not controlled by endogenous serine proteinase inhibitors. J Immunol 2000;165:3966-3969.
23. Barbara J Johnson, Costelloe EO, Fitzpatrick DR, Haanen JBAG, Schumacher TNM, Brown LE, Kelso A. Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice. PNAS 2002;100 (5):2657-2662.
24. Julián Pardo, Balkow S, Anel A, Simon MM. The differential contribution of granzyme A and granzyme B in cytotoxic T lymphocyte-mediated apoptosis is determined by the quality of target cells. Eur J Immunol 2002;32:1980-1985.
25. Masson D, Tschopp J. A family of serine esterases in lytic granules of cytolytic T lymphocytes. Cell 1987;49:679-685.
26. Mark J Smyth, Trapani JA. Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol Today 1995;16(4):202-206.
27. Satoru Hashimoto, Kobayashi A, Kooguchi K, Kitamura Y, Onodera H, Nakajima H. Upregulation of two death pathways of perforin/granzyme and FasL/Fas in septic acute respiratory distress syndrome. Am J Resp Crit Care Med 2000;161:237-243.
28. Christof Wagner, Iking-Konert C, Denefleh B, Stegmaier S, Hug F, Hänsch GM. Granzyme B and perforin: constitutive expression in human polymorphonuclear neutrophils. Blood 2004;103(3):1099-1104.
29. Kathrin Hochegger, Eller P, Rosenkranz AR. Granzyme A: an additional weapon of human polymorphonuclear neutrophils (PMNs). Blood 2004;103 (3):1176.
30. Ruili Shi, Yang J, Jaramillo A, Steward NS, Aloush A, Trulock EP, Patterson GA, Suthanthiran M, Mohanakumar T. Correlation between interleukin-15 and granzyme B expression and acute lung allograft rejection. Transplant Immunol 2004;12:103-108.
31. Shresta S, Heusel JW, Macivor DM, Wesselschmidt RL, Russel JH, Ley TJ. Granzyme B plays a critical role in cytotoxic lymphocyte-induced apoptosis. Immunol Rev 1995;146:211.
32. Baogui Li, Hartono C, Ding R, Sharma VK, Rasmawamy R, Qian B, et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 2001;344(13):947-954.
33. Jürgen Strehlau, Pavlakis M, Lipman M, Shapiro M, Vasconcellos L, Harmon W, Strom TB. Quantitaive detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci USA 1997;94(2):695-700.
34. Judy Lieberman, Fan Z. Nuclear war: the granzyme A-bomb. Curr Opin Immunol 2003;15:553-559.
35. MM Simon, Kramer MD, Prester M, Gay S. Mouse T-cell associated serine proteinase 1 degrades collagen type IV: a structural basis for migration of lymphocytes through vascular basement membranes. Immunology 1991;73:117-119.
36. Martin Irmler, Hertig S, MacDonald HR, Sadoul R, Becherer JD, Proudfoot A, Solari R, Tschopp J. Granzyme A is an interleukin 1 β-converting enzyme. J Exp Med 1995;181:1917-1922.
37. Laurie E Sower, Froelich CJ, Allegretto N, Rose PM, Hanna WD, Klimpel GR. Extracellular activities of human granzyme A. Monocyte activation by granzyme Aversus a-trombin. J Immunol 1996;156:2585-2590.
38. Laurie E Sower, Klimpel GR, Hanna W, Froelixch CJ. Extracellular activities of human granzymes. I. Granzyme A induces IL and IL8 production in fibroblast and epithelial cell fines. Cell Immunol 1996;171:159-163.
39. Hana S Suidan, Clemetson KJ, Brown-Luedi M, Niclou SP, Clemetson JM, Tschopp J, Monard D. The serine protease granzyme A does not induce platelet aggregation but inhibits responses triggered by thrombin. Biochem J 1996;315:939-945.
40. Christopher J Froelich, Zhang X, Turbov J, Hudig D, Winkler U, Hanna WL. Human granzyme B degrades aggrecan proteoglycan in matrix synthetized by chondrocytes. J Immunol 1993;151(12):7161-7171.
41. MM Simon, Simon HG, Fruth U, Epplen J, Müller-Hermelink HK, Kramer MD. Cloned cytolytic T-effector cells and their malignant variants produce an extracellular matrix degrading trypsin-tike serine proteinase. Immunology 1987;60:219-230.
42. Elisabeth HA Spaeny-Dekking, Hanna WL, Wolbink AM, Wever PC, Kummer AJ, Swaak AJG, et al. Extracellular granzymes A and B in humans: detection of native species during CTL responses in vitro and in vivo. J Immunol 1998;160:3610-3616.
43. Kai Bratke, Böttcher B, Leeder K, Schmidt S, Küpper M, Virchow JC, Luttmann W. Increase in granzyme B+ lymphocytes and soluble granzyme bronchoalverolar lavage of allergen challenged patients with atopic asthma. Clin Exp Immunol 2004;136(3):542-548.
44. Snjezana Rothkrantz-Kos, van Dieijen-Visser MP, Mulder PGH, Drent M. Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis. Clin Chem 2003 Sep;49(9):1510-1517.
45. Cyrile Bergoin, Lamblin C, Wallaert B. Biological manifestations of sarcoidosis (Manifestations biologiques au cours de la sarcoïdose). Ann Med Interne (Paris) 2001;152(1):34-38.
46. Baudin B. New aspects on angiotensin-converting enzyme: from gene to disease. Clin Chem Lab Med 2002;40(3):256-265.
47. Costabel U, Teschler H. Biochemical changes in sarcoidosis. Clin Chest Med 1997;18(4):827-842.
48. Beneteau-Burnat B, Baudin B. Angiotensin-converting enzyme: clinical applications and laboratory investigations on serum and other biological fluids. Crit Rev Clin Lab Sci 1991;28(5-6):337-356.
49. Laura VM. ACE: physiopathology and role in the diagnosis and prognosis of systemic granulomatosis, neoplasms and lung toxicity caused by antineoplastic agents. Recenti Prog Med 1990;81(9):601-613.
50. ACTM Peeters, Netea MG, Kulberg BJ, Thien T, Van der Meer JWM. The effect of renin-angiotensin system inhibitors on pro- and anti-inflammatory cytokine production. Immunology 1998;94:376-379.
51. Manfred Schurmann. Angiotensin-converting enzyme gene polymorphisms in patients with pulmonary sarcoidosis: impact on disease severity. Am J Pharmacogenomics 2003;3(4):233-243.
52. S Reitamo, Klockars M, Adinolfi M, Osserman EF. Human lysozyme (origin and distribution in health and disease). Ric Clin Lab 1978;8(4):211-231.
53. Joseph A Trapani. Granzymes: a family of lymphocyte granule serine proteases. Genome Biol 2001;2(12):Reviews3014.1-3014.7.
54. Robert V Talanian, Yang XH, Turbov J, Seth P, Ghayur T, Casiano CA, Orth K, Froelich CJ. Granule-mediated killing: pathways for granzyme B-initiated apoptosis. J Exp Med 1997;186(8):1323-1331.
55. Dong Zhang, Beresford PJ, Greenberg AH, Lieberman J. Granzymes A and B directly cleave lamins and disrupt the nuclear lamina during granule-mediated cytolysis. Proc Natl Acad Sci USA 2001;98(10):5746-51.
56. IJM ten Berge, Wever PC, Wolbink AM, Surachno J, Wertheim PME, Spaeny LHA, Hack CE. Increased systemic levels of soluble granzymes A and B during primary cytomegalovirus infection after renal transplantation. Transplant Proc 1998;30:3972-3974.
57. Tak PP, Spaeny-Dekking L, Kraan MC, Breedveld FC, Froelich CJ, Hack CE. The levels of soluble granzyme A and B are elevated in plasma and synovial fluid of patients with rheumatoid arthritis (RA). Clin Exp Immunol 1999; 116:366.